Correlation Between Vivos Therapeutics and Cross Country

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Cross Country at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Cross Country into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and Cross Country Healthcare, you can compare the effects of market volatilities on Vivos Therapeutics and Cross Country and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Cross Country. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Cross Country.

Diversification Opportunities for Vivos Therapeutics and Cross Country

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vivos and Cross is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Cross Country Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cross Country Healthcare and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Cross Country. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cross Country Healthcare has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Cross Country go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Cross Country

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 3.87 times more return on investment than Cross Country. However, Vivos Therapeutics is 3.87 times more volatile than Cross Country Healthcare. It trades about 0.17 of its potential returns per unit of risk. Cross Country Healthcare is currently generating about -0.05 per unit of risk. If you would invest  254.00  in Vivos Therapeutics on May 16, 2025 and sell it today you would earn a total of  207.00  from holding Vivos Therapeutics or generate 81.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vivos Therapeutics  vs.  Cross Country Healthcare

 Performance 
       Timeline  
Vivos Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cross Country Healthcare 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cross Country Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Cross Country is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Vivos Therapeutics and Cross Country Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivos Therapeutics and Cross Country

The main advantage of trading using opposite Vivos Therapeutics and Cross Country positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Cross Country can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will offset losses from the drop in Cross Country's long position.
The idea behind Vivos Therapeutics and Cross Country Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum